Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wing C Chan

Showing results (281-290 of 295) with videos related to

Pageof 30
Sort By:
Nature|June 22, 2018
A multiprotein supercomplex controlling oncogenic signalling in lymphomaJames D Phelan, Ryan M Young, Daniel E Webster, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 3, 2017
Outcomes after Allogeneic Stem Cell Transplantation in Patients with Double-Hit and Double-Expressor LymphomaAlex F Herrera, Scott J Rodig, Joo Y Song, et al.
The New England Journal of Medicine|April 12, 2018
Genetics and Pathogenesis of Diffuse Large B-Cell LymphomaRoland Schmitz, George W Wright, Da Wei Huang, et al.
Nature|January 8, 2010
Chronic active B-cell-receptor signalling in diffuse large B-cell lymphomaR Eric Davis, Vu N Ngo, Georg Lenz, et al.
American Journal of Hematology|June 13, 2025
Integrative Genomic and Transcriptomic Analysis Reveals Targetable Vulnerabilities in Angioimmunoblastic T-Cell LymphomaAlyssa Bouska, Weiwei Zhang, Sunandini Sharma, et al.
The New England Journal of Medicine|June 21, 2002
The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphomaAndreas Rosenwald, George Wright, Wing C Chan, et al.
Nature|August 14, 2012
Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomicsRoland Schmitz, Ryan M Young, Michele Ceribelli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2016
Relapsed or Refractory Double-Expressor and Double-Hit Lymphomas Have Inferior Progression-Free Survival After Autologous Stem-Cell TransplantationAlex F Herrera, Matthew Mei, Lawrence Low, et al.
Blood|February 21, 2019
Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphomaTayla B Heavican, Alyssa Bouska, Jiayu Yu, et al.
Cancer Discovery|January 27, 2017
The Genetic Basis of Hepatosplenic T-cell LymphomaMatthew McKinney, Andrea B Moffitt, Philippe Gaulard, et al.
Pageof 30

Showing results (281-290 of 295) with videos related to

Sort By:
Pageof 30
Nature|June 22, 2018
A multiprotein supercomplex controlling oncogenic signalling in lymphomaJames D Phelan, Ryan M Young, Daniel E Webster, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 3, 2017
Outcomes after Allogeneic Stem Cell Transplantation in Patients with Double-Hit and Double-Expressor LymphomaAlex F Herrera, Scott J Rodig, Joo Y Song, et al.
The New England Journal of Medicine|April 12, 2018
Genetics and Pathogenesis of Diffuse Large B-Cell LymphomaRoland Schmitz, George W Wright, Da Wei Huang, et al.
Nature|January 8, 2010
Chronic active B-cell-receptor signalling in diffuse large B-cell lymphomaR Eric Davis, Vu N Ngo, Georg Lenz, et al.
American Journal of Hematology|June 13, 2025
Integrative Genomic and Transcriptomic Analysis Reveals Targetable Vulnerabilities in Angioimmunoblastic T-Cell LymphomaAlyssa Bouska, Weiwei Zhang, Sunandini Sharma, et al.
The New England Journal of Medicine|June 21, 2002
The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphomaAndreas Rosenwald, George Wright, Wing C Chan, et al.
Nature|August 14, 2012
Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomicsRoland Schmitz, Ryan M Young, Michele Ceribelli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2016
Relapsed or Refractory Double-Expressor and Double-Hit Lymphomas Have Inferior Progression-Free Survival After Autologous Stem-Cell TransplantationAlex F Herrera, Matthew Mei, Lawrence Low, et al.
Blood|February 21, 2019
Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphomaTayla B Heavican, Alyssa Bouska, Jiayu Yu, et al.
Cancer Discovery|January 27, 2017
The Genetic Basis of Hepatosplenic T-cell LymphomaMatthew McKinney, Andrea B Moffitt, Philippe Gaulard, et al.
Pageof 30